A Phase II trial of dendritic cell (DC) immunotherapy for hepatocellular carcinoma (ANNALS OF ONCOLOGY, 2004)

(untitled) - Midgley, R; Kerr, D; Palmer, D; Mirza, N; Milner, A; Adams, D